a vaccine made from immune system cells taken from a patient with prostate cancer and frozen for future use. the cells are treated in the laboratory with a growth factor attached to a protein called prostatic-acid phosphatase (pap), which is found on prostate cancer cells. when apc8015f is injected into the patient, it may cause t cells (a type of white blood cell) to kill tumor cells that have pap on them.